Gland Pharma Limited (NSE:GLAND)
1,929.50
+23.70 (1.24%)
Oct 31, 2025, 3:30 PM IST
Gland Pharma Employees
Gland Pharma had 4,351 employees as of March 31, 2025. The number of employees increased by 134 or 3.18% compared to the previous year.
Employees
4,351
Change (1Y)
134
Growth (1Y)
3.18%
Revenue / Employee
13.15M INR
Profits / Employee
1.77M INR
Market Cap
317.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4,351 | 134 | 3.18% |
| Mar 31, 2024 | 4,217 | -368 | -8.03% |
| Mar 31, 2023 | 4,585 | -54 | -1.16% |
| Mar 31, 2022 | 4,639 | 678 | 17.12% |
| Mar 31, 2021 | 3,961 | 170 | 4.48% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Gland Pharma News
- 2 days ago - Gland Pharma Ltd (NSE:GLAND) Q2 2026 Earnings Report Preview: What To Expect - GuruFocus
- 5 weeks ago - These Indian pharma stocks tumble as Trump announces 100% tariff on branded drugs - Business Upturn
- 5 weeks ago - Gland Pharma shares fall over 4% as Trump announces 100% tariff on pharma imports - Business Upturn
- 5 weeks ago - Gland Pharma down 4%, Sun Pharma slips 2.6%, Dr Reddy’s down 2%, Zydus nearly 3%, Aurobindo down 2% as Trump’s 100% pharma tariff jolts sector - Business Upturn
- 2 months ago - Gland Pharma gets USFDA nod for Vasopressin in 5% Dextrose RTU Injection - Business Upturn
- 2 months ago - Gland Pharma gets USFDA approval for Cangrelor injection with 180-day exclusivity - Business Upturn
- 3 months ago - Gland Pharma shares jump 4% as Q1 revenue rises 7% YoY to Rs 1,505.6 crore, net profit up 50% YoY - Business Upturn
- 3 months ago - Top stocks to watch today, August 6: Bharti Airtel, Lupin, Britannia, NCC, Gland Pharma and more - Business Upturn